Brief: Phathom Pharmaceuticals Announces FDA Approval Of Voquezna® (Vonoprazan) Tablets For The Relief Of Heartburn Associated With Non-Erosive Gerd In Adults

Phathom Pharmaceuticals

18/07/2024 13:41

July 18 (Reuters) - Phathom Pharmaceuticals Inc
 PHAT.O :
    * PHATHOM PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF
VOQUEZNA®
(VONOPRAZAN) TABLETS FOR THE RELIEF OF HEARTBURN ASSOCIATED WITH
NON-EROSIVE GERD IN ADULTS
    * PHATHOM PHARMACEUTICALS INC: VOQUEZNA MET ITS PRIMARY
ENDPOINT
IN ITS PHASE 3 PIVOTAL TRIAL

Source text for Eikon:  ID:nGNX8T8v8l 
Further company coverage:  PHAT.O 

 ((Reuters.Briefs@thomsonreuters.com;))